Frequency of lymphoceles after open and laparoscopic pelvic lymph node dissection in patients with prostate cancer

Scandinavian Journal of Urology and Nephrology

Volumn 37, Issue 3, 2003, Pages 218-221

  Solberg, Arne ^a   Angelsen, Anders ^a   Bergan, Unni ^a   Haugen, Olav A ^a   Viset, Trond ^a   Klepp, Olbjørn ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Lymphocele; Pelvic lymph node dissection; Prostate cancer; Staging

Indexed keywords

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPH NODE; PELVIS SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; SURGICAL TECHNIQUE; TUMOR VOLUME;

AGE DISTRIBUTION; AGED; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LAPAROSCOPY; LAPAROTOMY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHOCELE; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 0038049451     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365590310008082     Document Type: Article

References (16)

1. Partin AW, Kattan MW, Subong EN, Walsh PC, Wonjno KJ, Oesterling JE, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional study. JAMA 1997; 277: 1445-51.
2. Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM. Biological determinants of cancer progression in men with prostate cancer. JAMA 1999; 281: 395-400.
3. Wawroschek F, Weckermann D, Hamm M, Vogt H. Lymphknotenmetastasierung beim Prostatakarzinom - haufigkeit, diagnostik und klinische konsequenzen. Klinikartzt 1999; 28: 348-51.
4. Bishoff JT, Reyes A, Thompson IM, Harris MJ, St Clair SR, Gomella L, et al. Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. Urology 1995; 45: 270-4.
5. Meng MV, Caroll PR. When is pelvic lymphnode dissection necessary before radical prostatectomy? A decision analysis. J Urol 2000; 164: 1235-40.
6. Batuello JT, Gamito EJ, Crawford ED, Han M, Partin AW, McLeod DG, et al. Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer. Urology 2001; 57: 481-5.
7. Gervasi LA, Mata J, Easley JD, Wilbanks JH, Seale-Hawkins C, Carlton CE Jr, et al. Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 1989; 142: 332-6.
8. Bratt O, Elfving P, Flodgren P, Lundgren R. Morbidity of pelvic lymphadenectomy, radical retropubic prostatectomy and external radiotherapy in patients with localised prostatic cancer. Scand J Urol Nephrol 1994; 28: 265-71.
9. Sogani PC, Watson RC, Whitmore WF Jr. Lymphocele after pelvic lymphadenectomy for urologic cancer. Urology 1981; 17: 39-43.
10. Ojeda L, Sharifi R, Lee M, Mouli K, Guinan P. Lymphocele formation after extraperitoneal pelvic lymphadenectomy: possible predisposing factors. J Urol 1986; 136: 616-8.
11. Spring DB, Schroeder D, Babu S, Agee R, Gooding GAW. Ultrasonic evaluation of lymphocele formation after staging lymphadenectomy for prostate carcinoma. Radiology 1981; 141: 479-83.
12. Fried RM, Siegel D, Smith AD, Weiss GH. Lymphoceles after laparoscopic pelvic node dissection. Urology 1998; 51 (5A Suppl): 131-4.
13. Mostofi FK, Sesterhenn I, Sobin LH. Histological typing of prostate tumors. International Histological Classification of Tumors, No. 22. Geneva, Switzerland: World Health Organisation, 1980.
14. Stutman LJ, Dumont AE, Shinowara GY. Coagulation factors in human lymph and plasma. Am J Med Sci 1965; 250: 292-7.
15. Mori N. Clinical and experimental studies on so-called lymphocyst which develops after radical hysterectomy in cancer of uterine cervix. J Jpn Soc Obstet Gynecol 1955; 2: 178.
16. Tomic R, Granfors T, Sjødin J-G, Øhberg L. Lymph leakage after staging pelvic lymphadenectomy for prostatic carcinoma with and without heparin prophylaxis. Scand J Urol Nephrol 1994; 28: 273-5.